ArticleBlood vessels, thrombosis & hemostasis2024
EASIX and m-EASIX predict severe cytokine release syndrome and overall survival after CAR T-cell therapy.
Abstract read
In one paragraph
Article in Blood vessels, thrombosis & hemostasis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Longitudinal Cognitive Assessment After CAR-T Cell Immunotherapy: A Prospective Cohort Study.Cancers · 2026Article
- Prognostic Role of the Endothelial Activation and Stress Index (EASIX) in Functional Outcomes and Mortality After Acute Ischemic Stroke: A Retrospective Pilot Cohort Study.Journal of cardiovascular development and disease · 2026Article
- Patterns of immune recovery after axicabtagene ciloleucel for aggressive B-cell lymphoma.HemaSphere · 2025Article
- Review
- Chimeric Antigen Receptor T Cell Immunotherapy for Autoimmune Rheumatic Disorders: Where Are We Now?Cells · 2025Review
- Invasive Fungal Disease After Chimeric Antigen Receptor-T Immunotherapy in Adult and Pediatric Patients.Pathogens (Basel, Switzerland) · 2025Review
- Endothelial dysfunction and hemostatic imbalance in CAR T-cell-associated toxicities: pathophysiological insights and the role of circulating biomarkers.Frontiers in immunology · 2025Review
- Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR), Growth Differentiation Factor-15 (GDF-15), and Soluble C5b-9 (sC5b-9) Levels Are Significantly Associated with Endothelial Injury Indices in CAR-T Cell Recipients.International journal of molecular sciences · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
29 authors.
Eleni GavriilakiHematology Department, Bone Marrow Transplantation Unit, G. Papanicolaou General Hospital of Thessaloniki, Thessaloniki, Greece.
Ifigeneia TzannouHematology and Lymphomas Department and Bone Marrow Transplantation Unit, Evangelismos General Hospital, Athens, Greece.
Ioannis BatsisHematology Department, Bone Marrow Transplantation Unit, G. Papanicolaou General Hospital of Thessaloniki, Thessaloniki, Greece.
Ioannis TsonisHematology and Lymphomas Department and Bone Marrow Transplantation Unit, Evangelismos General Hospital, Athens, Greece.
Maria LigaHematology Department, Bone Marrow Transplantation Unit and Institute of Cell Therapy, University of Patras, Rio, Greece.
Konstantinos GkirkasSecond Department of Internal Medicine, Hematology Unit, National and Kapodistrian University of Athens, School of Medicine, Attikon University Hospital, Athens, Greece.
Maria XimeriDepartment of Hematology, University Hospital of Heraklion, Heraklion, Greece.
Panagiotis DolgyrasHematology Department, Bone Marrow Transplantation Unit, G. Papanicolaou General Hospital of Thessaloniki, Thessaloniki, Greece.
Vasiliki BampaliHematology and Lymphomas Department and Bone Marrow Transplantation Unit, Evangelismos General Hospital, Athens, Greece.
Paschalis EvangelidisSecond Propedeutic Department of Internal Medicine, Hematology Unit, Hippocration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Zoi BousiouHematology Department, Bone Marrow Transplantation Unit, G. Papanicolaou General Hospital of Thessaloniki, Thessaloniki, Greece.
Anna VardiHematology Department, Bone Marrow Transplantation Unit, G. Papanicolaou General Hospital of Thessaloniki, Thessaloniki, Greece.
Christos DemosthenousHematology Department, Bone Marrow Transplantation Unit, G. Papanicolaou General Hospital of Thessaloniki, Thessaloniki, Greece.
Eulampia StroggyliHematology Department, Bone Marrow Transplantation Unit, G. Papanicolaou General Hospital of Thessaloniki, Thessaloniki, Greece.
Maria BouzaniHematology and Lymphomas Department and Bone Marrow Transplantation Unit, Evangelismos General Hospital, Athens, Greece.
Eleftheria SagiadinouHematology Department, Bone Marrow Transplantation Unit and Institute of Cell Therapy, University of Patras, Rio, Greece.
Despina MallouriHematology Department, Bone Marrow Transplantation Unit, G. Papanicolaou General Hospital of Thessaloniki, Thessaloniki, Greece.
Tatiana TzenouHematology and Lymphomas Department and Bone Marrow Transplantation Unit, Evangelismos General Hospital, Athens, Greece.
Damianos SotiropoulosHematology Department, Bone Marrow Transplantation Unit, G. Papanicolaou General Hospital of Thessaloniki, Thessaloniki, Greece.
Stavros GigantesHematology and Lymphomas Department and Bone Marrow Transplantation Unit, Evangelismos General Hospital, Athens, Greece.
Achilles AnagnostopoulosHematology Department, Bone Marrow Transplantation Unit, G. Papanicolaou General Hospital of Thessaloniki, Thessaloniki, Greece.
Dimitrios KarakasisHematology and Lymphomas Department and Bone Marrow Transplantation Unit, Evangelismos General Hospital, Athens, Greece.
Helen PapadakiDepartment of Hematology, University Hospital of Heraklion, Heraklion, Greece.
Panagiotis TsirigotisSecond Department of Internal Medicine, Hematology Unit, National and Kapodistrian University of Athens, School of Medicine, Attikon University Hospital, Athens, Greece.
Alexandros SpyridonidisHematology Department, Bone Marrow Transplantation Unit and Institute of Cell Therapy, University of Patras, Rio, Greece.
Theodoros VassilakopoulosDepartment of Haematology and Bone Marrow Transplantation, School of Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Maria AngelopoulouDepartment of Haematology and Bone Marrow Transplantation, School of Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Ioanna SakellariHematology Department, Bone Marrow Transplantation Unit, G. Papanicolaou General Hospital of Thessaloniki, Thessaloniki, Greece.
Ioannis BaltadakisHematology and Lymphomas Department and Bone Marrow Transplantation Unit, Evangelismos General Hospital, Athens, Greece.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.